Medical Marketing and Media - Plenaxis faces unusual marketing rules
January 1, 2004 -- IN A BOLD TEST of its new risk-management strategy, FDA has included unusual marketing and distribution restrictions in its Nov. 25 approval of...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Provides Update on Plenaxis Commercialization
December 6, 2004 -- WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today provided an update on the Company's commercialization of Plenaxis(R)...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis® Disposition Efforts; Plans to Explore Financing Alternatives and Other Strategic...
June 20, 2006 -- WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today reported that it will not be able to enter into by June 30, 2006 a...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Provides Update on Marketing Authorization Application for Plenaxis in Germany
March 25, 2005 -- WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today provided an update on the status of its marketing authorization...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Announces Issuance of Final National Coverage Determination for Plenaxis
March 16, 2005 -- WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that the Centers for Medicare and Medicaid Services (CMS) has...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Receives FDA Approval for Plenaxis
November 25, 2003 -- Business Editors/Health/Medical Writers WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 25, 2003 PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Announces Issuance of Draft National Coverage Determination for Plenaxis
December 20, 2004 -- WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today announced that the Centers for Medicare and Medicaid Services (CMS) has...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Announces Resubmission of Plenaxis NDA
February 26, 2003 -- Business Editors/Health/Medical Writers WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 26, 2003 PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2004 Financial Results and Provides Update on Plenaxis Commercialization and Clinical Development...
October 29, 2004 -- WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced consolidated financial results for the three and nine months...
Business Wire - PRAECIS PHARMACEUTICALS INCORPORATED Announces First European Regulatory Submission for Plenaxis
June 23, 2003 -- Business Editors WALTHAM, Mass.--(BUSINESS WIRE)--June 23, 2003 PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that it has...
